ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 235 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $138,098,877 | -15.8% | 354,345 | -19.5% | 0.16% | -20.0% |
| Q1 2023 | $164,022,011 | +96141.8% | 440,233 | -2.1% | 0.20% | -16.7% |
| Q4 2022 | $170,427 | -99.9% | 449,878 | -10.2% | 0.25% | -6.1% |
| Q3 2022 | $176,840,000 | -18.0% | 500,893 | -12.0% | 0.26% | -12.7% |
| Q2 2022 | $215,773,000 | +32.7% | 569,502 | +10.5% | 0.30% | +63.0% |
| Q1 2022 | $162,556,000 | +27.8% | 515,544 | +41.9% | 0.18% | +44.9% |
| Q4 2021 | $127,210,000 | +23.9% | 363,260 | +6.4% | 0.13% | +12.4% |
| Q3 2021 | $102,674,000 | – | 341,404 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
| Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
| Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
| MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
| AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
| EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
| INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
| Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
| DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
| Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |